PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Cellular and Molecular Medicine, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, BS8 1TD, UK.\', \'Department of Clinical Laboratory Sciences, King Saud University, Riyadh, Saudi Arabia.\', \'Proteomics Facility, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, BS8 1TD, UK.\', \'Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.\', \'School of Cellular and Molecular Medicine, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, BS8 1TD, UK. d.a.matthews@bristol.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13073-021-00859-1
?:hasPublicationType
?:journal
  • Genome medicine
is ?:pmid of
?:pmid
?:pmid
  • 33722288
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.537
?:rankingScore_hIndex
  • 55
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all